Arthneeti
All Q2 FY27 results →
MH

Max Healthcare Institute Ltd

Q2 FY27Healthcare Services

Max Healthcare Institute Q2 Results 2026 (FY27): Revenue ₹3,219 Cr, PAT ₹448 Cr

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹851
Market cap₹82.8K Cr
P/E55.3
Updated30 Oct 2026
Read4 min read

Max Healthcare Institute Ltd Q2 FY27 key numbers

Revenue
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY.

As stated in Max Healthcare Institute Ltd's Q2 FY27 investor presentation · published 30 Oct 2026. Reported figures, not investment advice.

Based on Max Healthcare Institute Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) - Q2 FY27 Net Revenue: ₹3,055 Cr, up 18% YoY (Page 4, 21) - Q2 FY27 Operating EBITDA: ₹820 Cr, up 18% YoY; Margin ~26.8% (Page 4, 21) - Q2 FY2 EBITDA for Q2 FY27: ₹820 Cr, margin 26.8%, with an 18% YoY growth (Page 21, Page 4) - Operating EBITDA margin for Q2 FY27: 26.8% (Page 21, Page 4) - Profit After Tax (PAT) for Q2 FY27: ₹448 Cr, ma

From Max Healthcare Institute Ltd's Q2 FY27 earnings-call transcript · updated 30 Oct 2026.

Revenue & Sales Performance

  • Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17)
  • Q2 FY27 Net Revenue: ₹3,055 Cr, up 18% YoY (Page 4, 21)
  • Q2 FY27 Operating EBITDA: ₹820 Cr, up 18% YoY; Margin ~26.8% (Page 4, 21)
  • Q2 FY27 Profit After Tax (PAT): ₹448 Cr, up 10% YoY (Page 4, 17, 21)
  • Q2 FY27 Operational Beds: 5,518, up 16% YoY (Page 17)
  • Inpatient Volumes Q2 FY27: 98,464 patients, up 12% YoY (Page 18)
  • Outpatient Consults Q2 FY27: 1,144,000, up 13% YoY (Page 18)
  • Average Length of Stay (ALOS) steady at 3.9 days (Page 18)

2 more points from Max Healthcare Institute Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Max Healthcare Institute Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Capital expenditure of ₹ 415 Cr approved for addition of 209 brownfield beds across existing hospitals, including 85 beds at MSSH Noida, 60 beds at MSSH Vaishali, and 64 beds plus Multi-Level Car Parking tower at BLK-Max; construction commenced with commissioning targeted in Q4 FY30 (Page 22, 12, 3).
  • Commissioning of Oncology Block at MSSH Dwarka including Chemotherapy Day Care Unit, Dialysis Centre, LINAC, PET-CT, and Pathology Lab; will raise main hospital bed capacity to 318 beds in Q3 FY27 (Pages 12, 3).
  • Greenfield hospital land parcels acquired: ~1,000 beds potential in Gurgaon and ~550 beds in Lucknow (Page 39).
  • Acquisition of 250-bed Kalinga Hospital in Bhubaneswar; controlling stake (~66.34%) held post-rights issue and secondary purchase (Pages 12, 3).

2 more points from Max Healthcare Institute Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
1Health X Platform
Rev 1Mar 1
2Chandan Healthca
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 2
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Max Healthcare Institute Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Specifically: - Growth avenues discussed include capacity expansion (brownfield and greenfield), M&A, and digital platform initiatives rather than order or contract backlog. - Definitions and financial statements relate to healthcare service delivery metrics, not order backlog concepts typically found in manufacturing or project-based businesses.

Max Healthcare Institute Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.6K Cr, net profit ₹414 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Max Healthcare Institute Ltd's management said in earlier quarters

Others in Healthcare Services this season

  • Narayana Hrudayalaya Ltd (Q2 FY27)

    Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27

  • Artemis Medicare Services Ltd (Q2 FY27)

    Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service

  • Indegene Ltd (Q2 FY27)

    Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) . Key investor presentation takeaways from Indegene Ltd's Q2 FY27 investo

  • Aatmaj Healthcare Ltd (Q2 FY27)

    Revenue from operations for H1 FY 26-27: ₹1,695.98 million vs ₹1,081.04 million in H1 FY 25-26, reflecting a 54% growth (Page 13 & 14). Key investor presentatio

Compare:vs Apollo Hospitals Enterprise Ltdvs Manipal Health Enterprises Ltdvs Aster DM Quality Care Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Max Healthcare Institute Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Max Healthcare Institute Ltd Q2 FY27 results?

Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) - Q2 FY27 Net Revenue: ₹3,055 Cr, up 18% YoY (Page 4, 21) - Q2 FY27 Operating EBITDA: ₹820 Cr, up 18% YoY; Margin ~26.8% (Page 4, 21) - Q2 FY2 EBITDA for Q2 FY27: ₹820 Cr, margin 26.8%, with an 18% YoY growth (Page 21, Page 4) - Operating EBITDA margin for Q2 FY27: 26.8% (Page 21, Page 4) - Profit After Tax (PAT) for Q2 FY27: ₹448 Cr, ma

What is Max Healthcare Institute Ltd share price analysis?

Max Healthcare Institute Ltd currently shows a neutral. The stock trades at a P/E of 55.3 with a market cap of ₹82,843 Cr. Investors should review the full earnings analysis for detailed insights.

Is Max Healthcare Institute Ltd planning capital expenditure?

Capital expenditure of ₹ 415 Cr approved for addition of 209 brownfield beds across existing hospitals, including 85 beds at MSSH Noida, 60 beds at MSSH Vaishali, and 64 beds plus Multi-Level Car Parking tower at BLK-Max; construction commenced with commissioning targeted in Q4 FY30 (Page 22, 12, 3).

Keep Max Healthcare Institute Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.